Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Short term Debt: 2021-2024

Historic Short term Debt for Biofrontera (BFRI) over the last 1 years, with Jun 2024 value amounting to $296,000.

  • Biofrontera's Short term Debt was N/A to $296,000 in Q2 2024 from the same period last year, while for Jun 2024 it was $296,000, marking a year-over-year change of. This contributed to the annual value of $3.9 million for FY2023, which is 43.76% down from last year.
  • Per Biofrontera's latest filing, its Short term Debt stood at $296,000 for Q2 2024, which was down 87.43% from $2.4 million recorded in Q1 2024.
  • In the past 5 years, Biofrontera's Short term Debt ranged from a high of $7.2 million in Q3 2023 and a low of $296,000 during Q2 2024.
  • Its 3-year average for Short term Debt is $4.4 million, with a median of $3.9 million in 2023.
  • As far as peak fluctuations go, Biofrontera's Short term Debt soared by 122.42% in 2023, and later plummeted by 66.51% in 2024.
  • Biofrontera's Short term Debt (Quarterly) stood at $3.2 million in 2021, then surged by 114.13% to $6.9 million in 2022, then plummeted by 43.76% to $3.9 million in 2023, then plummeted by 66.51% to $296,000 in 2024.
  • Its Short term Debt was $296,000 in Q2 2024, compared to $2.4 million in Q1 2024 and $3.9 million in Q4 2023.